ASSOCIATION BETWEEN A SINGLE-NUCLEOTIDE POLYMORPHISM OF INTERLEUKIN 28B AND MUTATIONS IN THE CORE AND NS5A REGION OF HEPATITIS C VIRUS GENOTYPE 1B WITH RESPONSE TO PEGYLATED-INTERFERON-ALPHA 2B AND RIBAVIRIN COMBINATION THERAPY

被引：0
|
作者：
Hayashi, Kazuhiko [1 ]
Katano, Yoshiaki [1 ]
Honda, Takashi [1 ]
Ishigami, Masatoshi [1 ]
Nakano, Isao [1 ]
Goto, Hidemi [1 ]
机构：
[1] Nagoya Univ, Nagoya, Aichi 4648601, Japan
来源：
HEPATOLOGY | 2010年 / 52卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
936
引用
收藏
页码：772A / 772A
页数：1
相关论文
共 50 条
  • [21] Correlation between mutations in the core and NS5A genes of hepatitis C virus genotypes 1a, 1b, 3a, 3b, 6f and the response to pegylated interferon and ribavirin combination therapy
    Kumthip, K.
    Pantip, C.
    Chusri, P.
    Thongsawat, S.
    Brien, A. O.
    Nelson, K. E.
    Maneekarn, N.
    JOURNAL OF VIRAL HEPATITIS, 2011, 18 (04) : e117 - e125
  • [22] Pegylated interferon monotherapy in patients with chronic hepatitis C with low viremia and its relationship to mutations in the NS5A region and the single nucleotide polymorphism of interleukin-28B
    Hayashi, Kazuhiko
    Katano, Yoshiaki
    Masuda, Hiroko
    Ishizu, Youji
    Kuzuya, Teiji
    Honda, Takashi
    Ishigami, Masatoshi
    Itoh, Akihiro
    Hirooka, Yoshiki
    Nakano, Isao
    Ishikawa, Tetsuya
    Urano, Fumihiro
    Yoshioka, Kentaro
    Toyoda, Hidenori
    Kumada, Takashi
    Goto, Hidemi
    HEPATOLOGY RESEARCH, 2013, 43 (06) : 580 - 588
  • [23] Mutational diversity of NS5A and NS3 during triple therapy (telaprevir, pegylated-interferon-α 2b and ribavirin) for genotype 1b chronic hepatitis C: The Kobe Hepatitis Therapeutic Group
    Bai, Fugui
    Yano, Yoshihiko
    Kim, Soo-Ryang
    Seo, Yasushi
    Miki, Akira
    Saito, Masaya
    Hirano, Hirotaka
    Momose, Kenji
    Minami, Akihiro
    Hatazawa, Yuri
    Hayakumo, Takanobu
    Widasari, Dewiyani Indah
    Rinonce, Hanggoro Tri
    Sugano, Masahiko
    Tani, Satoshi
    Yoon, Seitetsu
    Imoto, Susumu
    Azuma, Takeshi
    Hotta, Hak
    Hayashi, Yoshitake
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2014, 33 (06) : 1652 - 1656
  • [24] Ribavirin Pharmacokinetics and Interleukin 28B Plus Cytochrome P450 27B1 Single-Nucleotide Polymorphisms as Predictors of Response to Pegylated Interferon/Ribavirin Treatment in Patients Infected with Hepatitis C Virus Genotype 1/4
    D'Avolio, Antonio
    Ciancio, Alessia
    Siccardi, Marco
    Baietto, Lorena
    Simiele, Marco
    Cariti, Giuseppe
    Calcagno, Andrea
    Smedile, Antonina
    Cusato, Jessica
    Bonora, Stefano
    Rizzetto, Mario
    Di Perri, Giovanni
    HEPATOLOGY, 2011, 54 (06) : 2278 - 2279
  • [25] Interleukin 28B polymorphism predicts pegylated interferon plus ribavirin treatment outcome in chronic hepatitis C genotype 4
    De Nicola, Stella
    Aghemo, Alessio
    Rumi, Maria Grazia
    Galmozzi, Enrico
    Valenti, Luca
    Soffredini, Roberta
    De Francesco, Raffaele
    Prati, Gian Maria
    D'Ambrosio, Roberta
    Cheroni, Cristina
    Donato, Maria Francesca
    Colombo, Massimo
    HEPATOLOGY, 2012, 55 (02) : 336 - 342
  • [26] Mutations in NS5A region and et interferon response in hepatitis 1b infected patients
    Halimi, G
    Halfon, P
    Gerolami, V
    Castets, F
    Khiri, H
    Bourliere, M
    Gauthier, AP
    Cartouzou, G
    HEPATOLOGY, 1996, 24 (04) : 144 - 144
  • [27] Efficacy and Safety of Telaprevir, Pegylated Interferon α-2b and Ribavirin Triple Therapy in Japanese Patients Infected with Hepatitis C Virus Genotype 1b
    Kawaguchi, Yasunori
    Iwane, Shinji
    Kumagai, Takanori
    Yanagita, Kimihiko
    Yasutake, Tsutomu
    Ide, Yasushi
    Otsuka, Taiga
    Eguchi, Yuichiro
    Ozaki, Iwata
    Akiyama, Takumi
    Kawazoe, Seiji
    Mizuta, Toshihiko
    INTERNAL MEDICINE, 2015, 54 (20) : 2551 - 2560
  • [28] The importance of IL28B polymorphism in response to pegylated interferon α and ribavirin in chronic hepatitis caused by HCV genotype 1b
    Mach, Tomasz
    Ciesla, Andrzej
    Sanak, Marek
    Glowacki, Mikolaj
    Warunek, Wioleta
    Owczarek, Danuta
    Ciecko-Michalska, Irena
    PRZEGLAD GASTROENTEROLOGICZNY, 2012, 7 (01): : 38 - 42
  • [29] Mutations of hepatitis C virus NS5B region and the response to interferon plus ribavirin combination treatment
    Hamano, K
    Sakamoto, N
    Enomoto, N
    Izumi, N
    Asahina, Y
    Kurosaki, M
    Ueda, E
    Tanabe, Y
    Maekawa, S
    Watanabe, M
    GASTROENTEROLOGY, 2004, 126 (04) : A721 - A721
  • [30] A significant association of the substitution in position 2209 of NS5A of hepatitis C virus 1b infection and the response to standard, consensus, or pegylated interferon plus ribavirin therapy.
    Moriguchi, H
    Uemura, T
    Sato, C
    HEPATOLOGY, 2005, 42 (04) : 689A - 689A
12345